UnknownPhase 2NCT05124678
Pharmacogenetics-guided Isoniazid Dosing in TB-HIV
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Makerere University
- Principal Investigator
- Christine Sekaggya-Wiltshire, MBChB, PhDInfectious Diseases Institute-Kampala
- Intervention
- Isoniazid Tablets(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2021 – 2022
Study locations (1)
- Infectious Diseases Institute, Kampala, Uganda
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05124678 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- RECRUITINGNCT07451899TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung DiseaseUniversitas Padjadjaran
- RECRUITINGNCT06845618Blood Tuberculosis DNA Levels to Monitor Tuberculosis TreatmentUniversity of Oxford
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet